Loading...

ADGM ADAGIO MEDICAL HOLDINGS INC US FDA Inspections 8-K Filing

DG M

DGM

ADAGIO MEDICAL HOLDINGS INC

(ADGM)

2025 8-K

Financial Results Update

Annual Meeting Results

Quarterly Results

Annual Meeting Announcement

Private Placement Closed

Securities Agreement

Study Results Released

Enrollment Complete

CFO Appointment

Financial Update

Financial Statements

Financial Results

CFO Resignation

Management Change

Corporate Restructuring

Agreement Termination

Compliance Waiver

Director Resignation

Financial Results

Financial Restatement

Financial Restatement

External Links:

On October 1, 2025, Adagio Medical Holdings, Inc. announced the completion of enrollment for a pivotal FDA study on its vCLAS™ Cryoablation System, aimed at treating ventricular tachycardia. This is significant for the company as it advances their clinical trial efforts.

AI Assistant

ADAGIO MEDICAL HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.